Hernández BO, Fernández TS, Vázquez RN, Leiva QL, Falcón AY, Torres RU

Language: Spanish
References: 38
Page: 226-242
PDF size: 309.93 Kb.

ABSTRACT

A fundamental method to assure the quality of clinical laboratory tests is the use of reference materials. A problem we are faced with is the scarcity of these products in the domestic market, due their high cost. Objective: Evaluate the stability of an adult bovine serum enriched with the enzymes alanine aminotransferase (ALT, GPT), aspartate aminotransferase (AST, GPT), alkaline phosphatase (AP) and amylase. Methods: This enzyme-enriched matrix underwent real-time stability assessment during 12 months at two temperatures (refrigerated and frozen). An evaluation was made of the effect of glycerol on the enzymatic activity of extracts, as well as the effect of the preservatives propylene glycol and ethylene glycol on enzymatic stability. Results: The enzyme extracts obtained began to lose their biological activity at 15 days, irrespective of the storage temperature and the presence or absence of glycerol. The real time assessment of the enriched matrix showed that stability varied with time and enzyme type, irrespective of the preservative tested, and fell below acceptable limits of enzymatic activity after three months of storage at 4 ºC. Conclusions: A multienzyme reference material was obtained which was stable for a period of 3 months.

REFERENCES

1. Medical laboratories particular requirements for quality and competence. En: ISO 15189, I.O.f. Standardization. Editor. Geneva; 2003.

2. Panteghini MCF, Schumann G, Siekmann L. Establishing a reference system in clinical enzymology. Clin Chem Lab Med. 2001;39(9):795-800.

3. Rej R. Accurate enzyme activity measurements. Two decades of development in the commutability of enzyme quality control materials. Arch Pathol Lab Med. 1993;117:352-64.

4. Panteghini MBR, van Solinge WW. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. En: Burtis CA, Bruns DE, editors. Philadelphia: Elsevier Saunders; 2006.

5. Panteghini M., Traceability, reference systems and result comparability. Clin Biochem Rev. 2007;28:97-104.

6. Panteghini M, Traceability as a unique tool to improve standardization in laboratory medicine. Clin Biochem. 2009;42:236-40.

7. Vesper HWTL. Traceability in laboratory medicine. Clin Chem Lab Med. 2009;55:1067-75.

8. Regulación número 25/00. Requerimiento de los estudios de estabilidad para el registro de productos biológicos / biotecnológicos. CECMED 2000. Disponible en: http://www.cecmed.sld.cu/Docs/RegFarm/DRA/EEstabilidad/Reg/Reg_25-00.pdf

9. Infusino ISG, Ceriotti F Panteghini M. Standardization in clinical enzymology: a challenge for the theory of metrological traceability. Clin Chem Lab Med. 2010;48(3):301-07.

10. Regulación número 19/06. Requisitos y procedimientos para la liberación de lotes de productos biológicos. CRECED 2006. Disponible en: http://www.cecmed.sld.cu/Docs/RegFarm/DRA/LibLotes/Reg/Reg_19-06.pdf

11. Doellgast GFW. Purification of human placental alkaline phosphatase. Salt effects in affinity chromatography. Biochem J. 1974;141:103-112.

12. Brenna OPM, Pace M, Pietta PG. Affinity-chromatography purification of alkaline phosphatase from calf intestine. Biochem J. 1975;151(2):2916.

13. Latner A, Hodson A. Human liver alkaline phosphatase purified by affinity chromatography, ultracentrifugation and polyacrylamide-gel electrophoresis. Biochem J. 1976;159:697-705.

14. Bermeyer UH. Determination of GPT activity in blood. Ann Biol Clin. 1986;44:481-9.

15. Vassault A, Gafmeyer D, Naudin C, Dumont G, Bailly M, Henny J, et al. Validation de techniques de la SFBC. Protocole de validation de techniques (Document B). Ann Biol Clin. 1986;44:686-745.

16. Caraway T. Selected methods for the small clinical chemistry laboratory. Faulkner WR, Meites S. Vol. 9. Washington: AACC; 1982.

17. Örnemark U, Van Nevel L, Smeyers P, Harper C, Taylor PD. The international measurement evaluation program IMEP-17. Trace and minor constituents in human serum. EUR 20694 En: Report to participants. Part 2: Methodology and quantity specifications. Disponible en: http://www.irmm.jrc.be/html/interlaboratory_comparisons/imep/imep-7/IMEP17_report_part2

18. Infusino IBR, Panteghini M. Traceability in clinical enzymology. Clin Biochem Rev. 2007;28(4):155-61.

19. Lessinger JSF, Vialle A, Férard G, Myara A, Guéchot J, Imbert-Bismut F, et al. Le calibrage en enzymologie clinique: principe, conditions d'application et résultats. Anne Biol Clin 2002;60(3):281-6.

20. Schiele GF JM, Lessinger J. Henny Harmonisation des pratiques: application à la mesure d'activités enzymatiques utilisées en prévention, dépistage, diagnostic et surveillance thérapeutique. Ann Biol Clin 2001;59(3):291-7.

21. Gubern G, Canalias F, Gella FJ. Determination of a-amylase activity: methods, comparison and commutability study of several control materials. Clin Chem. 1995;43(4):342-6.

22. Férard G, Imbert-Bismut F, Messous D, Piton A, Ueda S, Poynard T, et al. A reference material for traceability of aspartate aminotransferase (AST) results. Clin Chem Lab Med. 2005;43(5):549-53.

23. Kuwa K, Umemoto M. Certified multi-enzyme reference material using recombinant enzymes for JCTLM traceability chain. Clin Chem. 2008;54(Suppl):A17980.

24. Koedam JC, Buitenhuis S, Schmidt E, Klauke R. Production and certification of secondary enzyme reference materials (ERMs). Part 1: Preparation of the sera and some of their properties. Clin Chem. 1986;32(10):1901-5.

25. Pazhang MKK, Ranjbar B, Hosseinkhani S. Effects of water-miscible solvents and polyhydroxy compounds on the structure and enzymatic activity of thermolysin. J Biotechnol. 2006;127(1):45-53.

26. Nascimento C, Lino PR, Ramos L, Almeida AJ, de Almeida IT, Leandro P. Polyol additives modulate the in vitro stability and activity of recombinant human phenylalanine hydroxylase. Appl Biochem Biotechnol. 2010;162(1):192-207.

27. Feng S. Effects of glycerol on the compaction and stability of the wild type and mutated rabbit muscle creatine kinase. Proteins. 2008;71(2):844-54.

28. Lavery CB, Macdonald MJ, Williams JB, Spencer CA, Burke AA, Irwin DJ, et al. Purification of peroxidase from Horseradish (Armoracia rusticana) roots. J Agric Food Chem. 2010;58(15):8471-6.

29. Polonis A. Effect of a thermal factor on various biochemical indicators in the plasma of chickens. Pol Arch Weter. 1982;23(3):49-55.

30. Miller KD, Light RW. Stability of adenosine deaminase during transportation. Chest. 2004;126(6):1933-7.

31. Copeland W, Nealon DA, Rej R. Effects of temperature on measurement of alkaline phosphatase activity. Clin Chem. 1985;31(2):185-90.

32. Eto A, Nakano N, Chikaura Y. Multienzyme control serum (Seraclear-HE) containing human enzymes from established cell lines and other sources. Evaluation as candidate working enzyme reference material for y-glutamyltransferase. Clin Chem. 1996;42(12):2008-14.

33. Jung K, Grützmann KD. Long-term stability of enzymes in human serum stored in liquid nitrogen. Enzyme. 1984;31(4):209-16.

34. Goldstein D, Harris H. Expression of alkaline phosphatase loci in mammalian tissues. Proc Nat Acad Sci USA. 1980;77(5):285760.

35. Lessinger JM, Arzoglou P, Ramos P, Visvikis A, Parashou S, Calam D, et al. Preparation and characterization of reference materials for human pancreatic lipase: BCR 693 (from human pancreatic juice) and BCR 694 (recombinant). Clin Chem Lab Med. 2003;41(2):169-76.

36. Toussaint B, Emons H, Schimmel HG, Bossert-Reuther S, Canalias F, Ceriotti F, et al. Traceability of values for catalytic activity concentration of enzymes: a certified reference material for aspartate transaminase. Clin Chem Lab Med. 2010;48(6):795-803.

37. Franzini C. Ethylene glycol-stabilized haemolysates as control material in haemoglobinometry. Clin Chim Acta. 1983;135(2):175-9.

38. Ruiz D, De Castr, RE. Effect of organic solvents on the activity and stability of an extracellular protease secreted by the haloalkaliphilic archaeon Natrialba magadii. J Ind Microbiol Biotechnol. 2007;34(2):111-5.